Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)
- PMID: 33178745
- PMCID: PMC7607097
- DOI: 10.21037/atm-20-4665
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)
Abstract
Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.
Keywords: Osteoarthritis (OA); development and evaluation (GRADE); grading of recommendations assessment; guideline.
2020 Annals of Translational Medicine. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4665). The authors have no conflicts of interest to declare.
References
-
- Glyn-Jones S, Palmer AJR, Agricola R, et al. Osteoarthritis. Lancet 2015;386:376-87. - PubMed
-
- Chinese Rheumatology Association . The guideline for diagnosis and treatment of osteoarthritis. Chin J Rheumatol 2010;14:416-9.
Publication types
LinkOut - more resources
Full Text Sources